Patent details
EP3075247 Title: CONJUGATES FOR CANCER THERAPY AND DIAGNOSIS
Basic Information
- Publication number:
- EP3075247
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP152005351
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- CONJUGATES FOR CANCER THERAPY AND DIAGNOSIS
- French Title of Invention:
- REMEDES CONJUGUES DE THERAPIE ET DIAGNOSTIC DU CANCER
- German Title of Invention:
- KONJUGATE FÜR DIE KREBSTHERAPIE UND -DIAGNOSE
- SPC Number:
Dates
- Filing date:
- 02/02/2005
- Grant date:
- 12/10/2022
- EP Publication Date:
- 05/10/2016
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 12/10/2022
- EP B1 Publication Date:
- 12/10/2022
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 02/02/2023
- Expiration date:
- 02/02/2025
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 05/10/2022
- Name:
- BioSight Ltd.
- Address:
- 3 Hayarden Street Airport City, P.O.Box 1083, Lod 7019802, Israel (IL)
Inventor
1
- Name:
- IZAKOVICH, Esther
- Address:
- Israel (IL)
2
- Name:
- GENGRINOVITCH, Stela
- Address:
- Israel (IL)
Priority
- Priority Number:
- 540334 P
- Priority Date:
- 02/02/2004
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 47/54; A61K 47/55; A01N 37/18; A61P 35/00; A61P 35/02;
Publication
European Patent Bulletin
- Issue number:
- 202241
- Publication date:
- 12/10/2022
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|